We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$6.92B
AUM Growth
-$827M
Cap. Flow
-$701M
Cap. Flow %
-10.13%
Top 10 Hldgs %
16.59%
Holding
568
New
141
Increased
95
Reduced
99
Closed
174

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$104M
2
AAPL icon
Apple
AAPL
+$94.1M
3
ATVI
Activision Blizzard
ATVI
+$86.9M
4
CRM icon
Salesforce
CRM
+$74.7M
5
PH icon
Parker-Hannifin
PH
+$74.6M

Sector Composition

Rank Sector Weight
1 Technology 23.8%
2 Industrials 16.35%
3 Healthcare 14.69%
4 Consumer Discretionary 10.31%
5 Financials 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSOD
326
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$957K 0.01%
17,462
-182,643
-91% -$10.3M
BRKR icon
327
Bruker
BRKR
$8.14B
$931K 0.01%
+21,202
New +$950K
HTGM
328
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$922K 0.01%
7,709
+6,575
+580% +$1.32M
RRGB icon
329
Red Robin
RRGB
$152M
$917K 0.01%
27,585
-131,119
-83% -$4.31M
KSU
330
DELISTED
Kansas City Southern
KSU
$910K 0.01%
+6,840
New +$853K
BB icon
331
BlackBerry
BB
$5.26B
$900K 0.01%
+171,429
New +$1.2M
STKL
332
DELISTED
SunOpta
STKL
$848K 0.01%
471,388
+284,801
+153% +$738K
GNCA
333
DELISTED
Genocea Biosciences, Inc.
GNCA
$841K 0.01%
289,899
-6,163
-2% -$21K
IGMS
334
DELISTED
IGM Biosciences
IGMS
$837K 0.01%
+47,134
New +$951K
FBIN icon
335
Fortune Brands Innovations
FBIN
$6.06B
$782K 0.01%
16,737
-27,256
-62% -$1.24M
GMDA
336
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$782K 0.01%
180,700
-40,529
-18% -$165K
DHI icon
337
D.R. Horton
DHI
$42.3B
$781K 0.01%
+14,810
New +$707K
ITT icon
338
ITT
ITT
$19.1B
$770K 0.01%
+12,591
New +$759K
MIRM icon
339
Mirum Pharmaceuticals
MIRM
$6.14B
$756K 0.01%
+75,177
New +$922K
VBIV
340
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$746K 0.01%
+52,787
New +$1.11M
KRTX
341
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$737K 0.01%
45,160
-25,000
-36% -$486K
WBT
342
DELISTED
Welbilt, Inc.
WBT
$727K 0.01%
+43,111
New +$700K
FSTX
343
CALL
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$688K 0.01%
50,000
CFRX
344
CALL
DELISTED
ContraFect Corporation
CFRX
$672K 0.01%
2,344
ZSAN
345
DELISTED
Zosano Pharma Corporation
ZSAN
$664K 0.01%
12,155
-6,738
-36% -$604K
PD icon
346
PagerDuty
PD
$902M
$658K 0.01%
+23,285
New +$893K
JAZZ icon
347
Jazz Pharmaceuticals
JAZZ
$16.7B
$657K 0.01%
+5,124
New +$687K
XFOR icon
348
CALL
X4 Pharmaceuticals
XFOR
$460M
$636K 0.01%
1,667
UPBD icon
349
Upbound Group
UPBD
$1.16B
$634K 0.01%
+24,584
New +$646K
CYPH
350
CALL
Cypherpunk Technologies Inc
CYPH
$73.3M
$602K 0.01%
51,429

Similar funds

Alyeska Investment Group's Q3 2019 Portfolio in Review

As of Q3 2019, Alyeska Investment Group held 568 positions worth $6.92B, down 11% from $7.75B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Alyeska Investment Group withdrew a net $701M in Q3 2019, closing 174 positions and reducing 99 holdings. Its most notable exit was Uber, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Alyeska Investment Group opened a new position in Apple worth $101M.

  • Alyeska Investment Group's largest Q3 2019 buy was Apple: 1,799,048 shares worth $101M.
  • Alyeska Investment Group added most to Microsoft in Q3 2019, an estimated $104M increase.
  • Alyeska Investment Group's biggest Q3 2019 reduction was Cognizant, cutting an estimated $76.6M.
  • Alyeska Investment Group fully exited Uber in Q3 2019, selling an estimated $133M.
  • Alyeska Investment Group's ten largest holdings make up 17% of its $6.92B portfolio in Q3 2019.
  • Alyeska Investment Group opened 141 new positions and closed 174 in Q3 2019.
  • Alyeska Investment Group's portfolio value fell 11% quarter-over-quarter to $6.92B.

Based on Alyeska Investment Group's 13F filing for Q3 2019, filed 14 Nov 2019.